Recall: D-0354-2025

Class II - Potentially Harmful

Class IIClassification

2025-03-21Initiated

OngoingStatus

Somerset Therapeutics Private Firm

Product

Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton)

Reason

Lack of Assurance of Sterility: Media fill with bacterial contamination

Distribution

U.S. Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.